Status:

UNKNOWN

Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy

Lead Sponsor:

Martha Haahr M.D

Collaborating Sponsors:

Odense University Hospital

Conditions:

Delayed Graft Function

Eligibility:

MALE

18+ years

Phase:

PHASE1

Brief Summary

Prostate cancer is the most common cancer among Danish men, and the incidence is increasing. Studies have shown a high number needed to treat for each saved prostate cancer related death. Since the tr...

Detailed Description

Prostate cancer is the most common cancer among Danish men, and the incidence is increasing. Studies have shown a high number needed to treat for each saved prostate cancer related death. After prost...

Eligibility Criteria

Inclusion

  • Men who have had prostate removed due to prostate cancer regardless bilateral nerve-sparing, unilateral nerve-sparing or non-nerve-sparing surgical technique.
  • Erectile dysfunction
  • Sexually active/ have sexual interest
  • We make no distinction for the patients are operated with

Exclusion

  • Absence of sexual interest.
  • Patients with impaired health condition where anesthesia would be a risk of complications.
  • BMI below 20.
  • Small amount of abdominal fat assessed by. Ct abdomen.
  • Patients on anticoagulant treatment.
  • Men with suspicion of residual tumor.

Key Trial Info

Start Date :

April 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2016

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT02240823

Start Date

April 1 2014

End Date

September 1 2016

Last Update

October 16 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Odense Universitet Hospital

Odense, Denmark, 5000